- Home
- FIP vs REPL Comparison
FIP vs REPL Comparison
Compare FIP & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIP
- REPL
- Stock Information
- Founded
- FIP 2021
- REPL 2015
- Country
- FIP United States
- REPL United States
- Employees
- FIP N/A
- REPL N/A
- Industry
- FIP Consumer Electronics/Appliances
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- FIP Industrials
- REPL Health Care
- Exchange
- FIP Nasdaq
- REPL Nasdaq
- Market Cap
- FIP 715.0M
- REPL 757.8M
- IPO Year
- FIP N/A
- REPL 2018
- Fundamental
- Price
- FIP $6.58
- REPL $9.40
- Analyst Decision
- FIP Buy
- REPL Strong Buy
- Analyst Count
- FIP 1
- REPL 7
- Target Price
- FIP $12.00
- REPL $20.83
- AVG Volume (30 Days)
- FIP 1.2M
- REPL 1.1M
- Earning Date
- FIP 07-31-2025
- REPL 08-07-2025
- Dividend Yield
- FIP 1.83%
- REPL N/A
- EPS Growth
- FIP N/A
- REPL N/A
- EPS
- FIP N/A
- REPL N/A
- Revenue
- FIP $345,123,000.00
- REPL N/A
- Revenue This Year
- FIP $65.61
- REPL N/A
- Revenue Next Year
- FIP $30.50
- REPL N/A
- P/E Ratio
- FIP N/A
- REPL N/A
- Revenue Growth
- FIP 5.70
- REPL N/A
- 52 Week Low
- FIP $3.10
- REPL $6.44
- 52 Week High
- FIP $10.46
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- FIP 59.51
- REPL 52.14
- Support Level
- FIP $6.04
- REPL $9.12
- Resistance Level
- FIP $6.45
- REPL $9.73
- Average True Range (ATR)
- FIP 0.27
- REPL 0.49
- MACD
- FIP -0.05
- REPL -0.06
- Stochastic Oscillator
- FIP 51.25
- REPL 48.89
About FIP FTAI Infrastructure Inc.
FTAI Infrastructure Inc is engaged in five segments; Railroad segment includes five freight railroads and one switching company that provide rail service to certain manufacturing and production facilities, the Jefferson Terminal segment consists of a multi-modal crude oil and refined products terminal and other related assets. Repauno segment consists of a 1,630-acre deep-water port located along the Delaware River with an underground storage cavern, a new multipurpose dock, a rail-to-ship transloading system, and multiple industrial development opportunities. Power and Gas segment is comprised of an equity method investment in Long Ridge, and Sustainability and Energy Transition segment is comprised of Aleon/Gladieux, Clean Planet, and CarbonFree.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.